Dan Ollendorf
@dano-hta.bsky.social
Clin epi / health economics, focus on the evidence and science, fan of sanity
Reposted by Dan Ollendorf
How Lindsey Halligan Completely Botched the James Comey Case
YouTube video by Machine Pun Kelly
youtube.com
November 25, 2025 at 2:01 PM
Reposted by Dan Ollendorf
Sarepta: Enough, For God's Sake | Science | AAAS share.google/WcxLae5lKrqy...
Sarepta: Enough, For God's Sake
share.google
November 5, 2025 at 6:11 PM
Sarepta: Enough, For God's Sake | Science | AAAS share.google/WcxLae5lKrqy...
Reposted by Dan Ollendorf
Great conversation on vaccine hesitancy (and all things US vaccine policy) hosted by the folks at @busph.bsky.social yesterday. Here’s the recording www.youtube.com/watch?v=FSCw...
Vaccine Hesitancy: Past, Present, and Future
YouTube video by Boston University School of Public Health
www.youtube.com
October 9, 2025 at 12:32 PM
Great conversation on vaccine hesitancy (and all things US vaccine policy) hosted by the folks at @busph.bsky.social yesterday. Here’s the recording www.youtube.com/watch?v=FSCw...
Reposted by Dan Ollendorf
Health Economics Methods Advisory Group Releases Draft Report: Assessing Treatment Benefits in HTA Decision-Making tinyurl.com/yc47dejv
Health Economics Methods Advisory Group Releases Draft Report: Assessing Treatment Benefits in HTA Decision-Making – Health Economics Methods Advisory
tinyurl.com
October 9, 2025 at 12:06 PM
Health Economics Methods Advisory Group Releases Draft Report: Assessing Treatment Benefits in HTA Decision-Making tinyurl.com/yc47dejv
Reposted by Dan Ollendorf
4.2 million people may lose coverage if Congress doesn't extend premium subsidies for ACA plans.
“These are your friends, neighbors, and colleagues who [will] lose insurance, and their health [will] suffer as a result.”— @rachelwerner.bsky.social in @bloomberg.com.
www.bloomberg.com/opinion/arti...
“These are your friends, neighbors, and colleagues who [will] lose insurance, and their health [will] suffer as a result.”— @rachelwerner.bsky.social in @bloomberg.com.
www.bloomberg.com/opinion/arti...
This Shutdown Fight Has Life-or-Death Consequences
At the heart of the fight over the government shutdown is the fate of health insurance for millions of Americans who may soon face an impossible choice: accept a significant increase in their premiums...
www.bloomberg.com
October 7, 2025 at 5:24 PM
4.2 million people may lose coverage if Congress doesn't extend premium subsidies for ACA plans.
“These are your friends, neighbors, and colleagues who [will] lose insurance, and their health [will] suffer as a result.”— @rachelwerner.bsky.social in @bloomberg.com.
www.bloomberg.com/opinion/arti...
“These are your friends, neighbors, and colleagues who [will] lose insurance, and their health [will] suffer as a result.”— @rachelwerner.bsky.social in @bloomberg.com.
www.bloomberg.com/opinion/arti...
Was great fun to write this with Sarah Emond! A value-based approach could be used to reduce traditional access barriers and possibly mitigate back-end legislative remedies...
How to make one line in the FDA Commissioner’s new drug review program into a force for affordable access for patients -- a new Health Affairs Scholar paper by ICER President and CEO Sarah Emond and Chief Scientific Officer Dan Ollendorf: tinyurl.com/32bexcd9
How to make one line in the FDA Commissioner's new drug review program into a force for affordable access for patients
Abstract. The FDA Commissioner's new National Priority Voucher program seeks to accelerate drug approvals for products meeting certain criteria. Interestin
tinyurl.com
October 6, 2025 at 5:42 PM
Was great fun to write this with Sarah Emond! A value-based approach could be used to reduce traditional access barriers and possibly mitigate back-end legislative remedies...
Reposted by Dan Ollendorf
Val and I checked repeatedly because we simply couldn't believe no national or local news organizations covered this letter from 18 AGs in support of trans youth care and against FTC overreach.
If you find any stories, let us know, but it seems to be our exclusive.
If you find any stories, let us know, but it seems to be our exclusive.
On Friday 18 blue state attorneys general BLASTED the Federal Trade Commission, telling it to back off trans youth healthcare and warning of an insidious attempt to reshape the regulation of medicine in the US.
And nobody covered it.
www.assignedmedia.org/breaking-new...
And nobody covered it.
www.assignedmedia.org/breaking-new...
State AGs Defend Trans Americans in Stunning Rebuke to Trump’s FTC — Assigned
Eighteen state Attorneys General unite to stand up in defense of trans Americans, in opposition to a Federal Trade Commission investigation into trans healthcare.
www.assignedmedia.org
October 1, 2025 at 3:10 PM
Val and I checked repeatedly because we simply couldn't believe no national or local news organizations covered this letter from 18 AGs in support of trans youth care and against FTC overreach.
If you find any stories, let us know, but it seems to be our exclusive.
If you find any stories, let us know, but it seems to be our exclusive.
Reposted by Dan Ollendorf
Institute for Clinical and Economic Review to Assess Vaccines for COVID-19: tinyurl.com/2tfn5pme
Institute for Clinical and Economic Review to Assess Vaccines for COVID-19 - ICER
Report will be subject of New England CEPAC meeting in June 2026.
tinyurl.com
September 29, 2025 at 8:31 PM
Institute for Clinical and Economic Review to Assess Vaccines for COVID-19: tinyurl.com/2tfn5pme
Reposted by Dan Ollendorf
I was back at 26 Federal Plaza today, where an ICE agent violently threw this bereft woman to the ground in front of her kids. She had not touched him. She did not pose any threat. She had to be taken to the hospital. (🎥: Elias Eliahu)
September 25, 2025 at 6:03 PM
I was back at 26 Federal Plaza today, where an ICE agent violently threw this bereft woman to the ground in front of her kids. She had not touched him. She did not pose any threat. She had to be taken to the hospital. (🎥: Elias Eliahu)
Reposted by Dan Ollendorf
A new paper led by Harvard Health Policy PhD student Ye Shen finds that, in the current policy environment, more than six in ten kids will have been enrolled in Medicaid for some period of time by their 18th birthday; the program is absolutley critical for children.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
September 24, 2025 at 3:43 PM
A new paper led by Harvard Health Policy PhD student Ye Shen finds that, in the current policy environment, more than six in ten kids will have been enrolled in Medicaid for some period of time by their 18th birthday; the program is absolutley critical for children.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Reposted by Dan Ollendorf
Here’s what a Ball State University employee said that led to their termination:
September 18, 2025 at 11:38 AM
Here’s what a Ball State University employee said that led to their termination:
Make your voice heard -- your opportunity to comment coming up! @htaiorg.bsky.social @cda-amc.bsky.social @nicecomms.bsky.social
The first HEMA Draft Report will be published on September 24th, which will be open to public comment until October 15th.
Mark your calendars and submit your public comments via public_comments@hemamethods.org!
Learn more: hemamethods.org
Mark your calendars and submit your public comments via public_comments@hemamethods.org!
Learn more: hemamethods.org
Health Economics Methods Advisory
hemamethods.org
August 18, 2025 at 3:07 PM
Make your voice heard -- your opportunity to comment coming up! @htaiorg.bsky.social @cda-amc.bsky.social @nicecomms.bsky.social
Reposted by Dan Ollendorf
The Health Economics Methods Advisory (HEMA) has a new website! hemamethods.org
HEMA was convened by leaders at 3 global HTA organizations: ICER, @nicecomms.bsky.social, and @cda-amc.bsky.social
to critically and independently examine and assess new methods and processes.
HEMA was convened by leaders at 3 global HTA organizations: ICER, @nicecomms.bsky.social, and @cda-amc.bsky.social
to critically and independently examine and assess new methods and processes.
Health Economics Methods Advisory
hemamethods.org
August 18, 2025 at 2:07 PM
The Health Economics Methods Advisory (HEMA) has a new website! hemamethods.org
HEMA was convened by leaders at 3 global HTA organizations: ICER, @nicecomms.bsky.social, and @cda-amc.bsky.social
to critically and independently examine and assess new methods and processes.
HEMA was convened by leaders at 3 global HTA organizations: ICER, @nicecomms.bsky.social, and @cda-amc.bsky.social
to critically and independently examine and assess new methods and processes.
Reposted by Dan Ollendorf
The first HEMA Draft Report will be published on September 24th, which will be open to public comment until October 15th.
Mark your calendars and submit your public comments via public_comments@hemamethods.org!
Learn more: hemamethods.org
Mark your calendars and submit your public comments via public_comments@hemamethods.org!
Learn more: hemamethods.org
Health Economics Methods Advisory
hemamethods.org
August 18, 2025 at 2:04 PM
The first HEMA Draft Report will be published on September 24th, which will be open to public comment until October 15th.
Mark your calendars and submit your public comments via public_comments@hemamethods.org!
Learn more: hemamethods.org
Mark your calendars and submit your public comments via public_comments@hemamethods.org!
Learn more: hemamethods.org
Reposted by Dan Ollendorf
New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...
www.healthaffairs.org/doi/10.1377/...
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
www.healthaffairs.org
August 4, 2025 at 9:09 PM
New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...
www.healthaffairs.org/doi/10.1377/...
@icer-review.bsky.social @tuftscevr.bsky.social @peterneumann11.bsky.social @pattysynnott.bsky.social
New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...
www.healthaffairs.org/doi/10.1377/...
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
www.healthaffairs.org
August 4, 2025 at 9:10 PM
New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...
www.healthaffairs.org/doi/10.1377/...
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
www.healthaffairs.org
August 4, 2025 at 9:09 PM
New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...
www.healthaffairs.org/doi/10.1377/...
#RIP to a kind, intelligent, and thoughtful researcher and evidence advocate. But as you can see from this @nytimes.com piece, also a true leader to the end:
www.nytimes.com/2025/08/03/h...
www.nytimes.com/2025/08/03/h...
A Cancer Patient Chose Assisted Death. That Wasn’t the Last Hard Choice.
www.nytimes.com
August 4, 2025 at 4:29 PM
#RIP to a kind, intelligent, and thoughtful researcher and evidence advocate. But as you can see from this @nytimes.com piece, also a true leader to the end:
www.nytimes.com/2025/08/03/h...
www.nytimes.com/2025/08/03/h...
Reposted by Dan Ollendorf
Great application of our CEA Registry at the #Vanderbilt Center for Health Economic Modeling: 11 international fellows from #LMICs used the Registry to conduct CEAs of public health interventions.
Read more at: tinyurl.com/88varaue
@peterneumann11.bsky.social #ISPOR
Read more at: tinyurl.com/88varaue
@peterneumann11.bsky.social #ISPOR
VUMC researchers host international fellows for economic evaluation, decision science training
Vanderbilt recently hosted 11 international fellows to provide training to help them address public health issues in their home countries.
tinyurl.com
July 23, 2025 at 8:12 PM
Great application of our CEA Registry at the #Vanderbilt Center for Health Economic Modeling: 11 international fellows from #LMICs used the Registry to conduct CEAs of public health interventions.
Read more at: tinyurl.com/88varaue
@peterneumann11.bsky.social #ISPOR
Read more at: tinyurl.com/88varaue
@peterneumann11.bsky.social #ISPOR
Reposted by Dan Ollendorf
Two weeks left to apply: Earn your #HEOR Certificate online from @tufts.edu with globally-recognized faculty like @peterneumann11.bsky.social, @dano-hta.bsky.social, James Chambers, and more from CEVR. Apply today!
Deadline is Aug. 1.
tinyurl.com/pr6drkhf
#RWE #pharma
Deadline is Aug. 1.
tinyurl.com/pr6drkhf
#RWE #pharma
Health Economics and Outcomes Research (HEOR) Certificate Program - Tufts CTSI
Overview The Tufts University Graduate School of Biomedical Sciences (GSBS) Clinical and Translational Science (CTS) Graduate Program is delighted to offer an accredited Certificate Program in Health ...
tinyurl.com
July 18, 2025 at 6:13 PM
Two weeks left to apply: Earn your #HEOR Certificate online from @tufts.edu with globally-recognized faculty like @peterneumann11.bsky.social, @dano-hta.bsky.social, James Chambers, and more from CEVR. Apply today!
Deadline is Aug. 1.
tinyurl.com/pr6drkhf
#RWE #pharma
Deadline is Aug. 1.
tinyurl.com/pr6drkhf
#RWE #pharma
Reposted by Dan Ollendorf
The Medsky feed is close to 200 likes, so if you can please support by liking, sharing, and pinning it!
I know this sounds silly but the more engagement the feed receives the more likely it is that people will see there’s a dedicated space on Bluesky to discuss and share healthcare information.
I know this sounds silly but the more engagement the feed receives the more likely it is that people will see there’s a dedicated space on Bluesky to discuss and share healthcare information.
July 8, 2025 at 7:03 PM
The Medsky feed is close to 200 likes, so if you can please support by liking, sharing, and pinning it!
I know this sounds silly but the more engagement the feed receives the more likely it is that people will see there’s a dedicated space on Bluesky to discuss and share healthcare information.
I know this sounds silly but the more engagement the feed receives the more likely it is that people will see there’s a dedicated space on Bluesky to discuss and share healthcare information.
Importantly, much work still to be done to explore the applicability of available frameworks and integration into #HTA processes. I look forward to the work ahead.
Traditional #valueassessment lacks methods to evaluate #oncology combination txs, posing challenges for drugmakers, HTA bodies, and payers.
In a new commentary in Frontiers in Pharmacology, CEVR’s Dan Ollendorf et al explore available frameworks and chart a path forward: tinyurl.com/kh84ueb4
In a new commentary in Frontiers in Pharmacology, CEVR’s Dan Ollendorf et al explore available frameworks and chart a path forward: tinyurl.com/kh84ueb4
Frontiers | Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
Combination therapies are a mainstay in cancer treatment, but reimbursement access can be limited, owing to complexities around value assessment and pricing,...
tinyurl.com
July 2, 2025 at 2:53 PM
Importantly, much work still to be done to explore the applicability of available frameworks and integration into #HTA processes. I look forward to the work ahead.
Reposted by Dan Ollendorf
Traditional #valueassessment lacks methods to evaluate #oncology combination txs, posing challenges for drugmakers, HTA bodies, and payers.
In a new commentary in Frontiers in Pharmacology, CEVR’s Dan Ollendorf et al explore available frameworks and chart a path forward: tinyurl.com/kh84ueb4
In a new commentary in Frontiers in Pharmacology, CEVR’s Dan Ollendorf et al explore available frameworks and chart a path forward: tinyurl.com/kh84ueb4
Frontiers | Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
Combination therapies are a mainstay in cancer treatment, but reimbursement access can be limited, owing to complexities around value assessment and pricing,...
tinyurl.com
July 2, 2025 at 2:45 PM
Traditional #valueassessment lacks methods to evaluate #oncology combination txs, posing challenges for drugmakers, HTA bodies, and payers.
In a new commentary in Frontiers in Pharmacology, CEVR’s Dan Ollendorf et al explore available frameworks and chart a path forward: tinyurl.com/kh84ueb4
In a new commentary in Frontiers in Pharmacology, CEVR’s Dan Ollendorf et al explore available frameworks and chart a path forward: tinyurl.com/kh84ueb4
Reposted by Dan Ollendorf
Pleased to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, supported by the Gordon and Betty Moore Foundation.
cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social
cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social
CEVR Welcomes 2025 CEA Registry Summer Fellows - Center for the Evaluation of Value and Risk in Health
cevr.tuftsmedicalcenter.org
June 17, 2025 at 5:27 PM
Pleased to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, supported by the Gordon and Betty Moore Foundation.
cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social
cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social
Excited to contribute to a special issue of @BMJ_EBM, offering timely analysis on India’s experience of institutionalizing health technology assessment, with lessons for other LMICs.
Read on to see an adaptation of a @icer-review.bsky.social HTA report for the Indian context! ⬇
bit.ly/4h2UGGC
Read on to see an adaptation of a @icer-review.bsky.social HTA report for the Indian context! ⬇
bit.ly/4h2UGGC
Celebrating Ten Years of the international Decision Support Initiative
Over the last decade, iDSI has partnered with countries to develop evidence-informed priority-setting institutions and processes. Read our blog for a summary of key successes, challenges, and lessons ...
bit.ly
June 10, 2025 at 1:24 PM
Excited to contribute to a special issue of @BMJ_EBM, offering timely analysis on India’s experience of institutionalizing health technology assessment, with lessons for other LMICs.
Read on to see an adaptation of a @icer-review.bsky.social HTA report for the Indian context! ⬇
bit.ly/4h2UGGC
Read on to see an adaptation of a @icer-review.bsky.social HTA report for the Indian context! ⬇
bit.ly/4h2UGGC